Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
China
Beijing Cancer Hospital, Beijing Sun Yat-sen University Cancer Center, Guangdong Affiliated Hospital of Hebei University, Hebei Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei